Unknown

Dataset Information

0

Host-Directed Therapy as a Novel Treatment Strategy to Overcome Tuberculosis: Targeting Immune Modulation.


ABSTRACT: Tuberculosis (TB) is one of the leading causes of mortality and morbidity, particularly in developing countries, presenting a major threat to the public health. The currently recommended long term treatment regimen with multiple antibiotics is associated with poor patient compliance, which in turn, may contribute to the emergence of multi-drug resistant TB (MDR-TB). The low global treatment efficacy of MDR-TB has highlighted the necessity to develop novel treatment options. Host-directed therapy (HDT) together with current standard anti-TB treatments, has gained considerable interest, as HDT targets novel host immune mechanisms. These immune mechanisms would otherwise bypass the antibiotic bactericidal targets to kill Mycobacterium tuberculosis (Mtb), which may be mutated to cause antibiotic resistance. Additionally, host-directed therapies against TB have been shown to be associated with reduced lung pathology and improved disease outcome, most likely via the modulation of host immune responses. This review will provide an update of host-directed therapies and their mechanism(s) of action against Mycobacterium tuberculosis.

SUBMITTER: Ahmed S 

PROVIDER: S-EPMC7168302 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Host-Directed Therapy as a Novel Treatment Strategy to Overcome Tuberculosis: Targeting Immune Modulation.

Ahmed Sultan S   Raqib Rubhana R   Guðmundsson Guðmundur Hrafn GH   Bergman Peter P   Agerberth Birgitta B   Rekha Rokeya Sultana RS  

Antibiotics (Basel, Switzerland) 20200107 1


Tuberculosis (TB) is one of the leading causes of mortality and morbidity, particularly in developing countries, presenting a major threat to the public health. The currently recommended long term treatment regimen with multiple antibiotics is associated with poor patient compliance, which in turn, may contribute to the emergence of multi-drug resistant TB (MDR-TB). The low global treatment efficacy of MDR-TB has highlighted the necessity to develop novel treatment options. Host-directed therapy  ...[more]

Similar Datasets

| S-EPMC7438556 | biostudies-literature
| S-EPMC8321570 | biostudies-literature
| S-EPMC6218626 | biostudies-literature
| S-EPMC6033279 | biostudies-literature
2024-01-10 | GSE222258 | GEO
| S-EPMC6226451 | biostudies-other
| S-EPMC8493473 | biostudies-literature
| S-EPMC10213533 | biostudies-literature
| S-EPMC8563828 | biostudies-literature
| S-EPMC8032898 | biostudies-literature